Literature DB >> 9925538

Human herpesvirus 8 DNA load in leukocytes of human immunodeficiency virus-infected subjects: correlation with the presence of Kaposi's sarcoma and response to anticytomegalovirus therapy.

G Boivin1, A Gaudreau, E Toma, R Lalonde, J P Routy, G Murray, J Handfield, M G Bergeron.   

Abstract

Specific human herpesvirus 8 (HHV-8) DNA sequences were found in leukocytes of 12 of 29 (41.4%) AIDS subjects with Kaposi's sarcoma (KS), whereas they were found in 4 of 43 (9.3%) AIDS subjects without KS (P = 0.003), although the peak HHV-8 DNA load in PCR-positive subjects with KS (mean, 425 copies per 0.2 microgram of DNA) did not significantly differ from the one found in PCR-positive patients without KS (mean, 218 copies). The use of intravenous ganciclovir or foscarnet therapy to treat cytomegalovirus disease did not affect the HHV-8 DNA load in seven patients for whom serial samples were analyzed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9925538      PMCID: PMC89083     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Kaposi's sarcoma and new herpesvirus.

Authors:  H Collandre; S Ferris; O Grau; L Montagnier; A Blanchard
Journal:  Lancet       Date:  1995-04-22       Impact factor: 79.321

2.  AIDS-associated Kaposi's sarcoma.

Authors:  J L Jones; D L Hanson; S Y Chu; J W Ward; H W Jaffe
Journal:  Science       Date:  1995-02-24       Impact factor: 47.728

3.  Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection.

Authors:  P S Moore; Y Chang
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

4.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

5.  Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction.

Authors:  M H Delfau; J P Kerckaert; M Collyn d'Hooghe; P Fenaux; J L Laï; J P Jouet; B Grandchamp
Journal:  Leukemia       Date:  1990-01       Impact factor: 11.528

6.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

7.  Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma.

Authors:  N Dupin; M Grandadam; V Calvez; I Gorin; J T Aubin; S Havard; F Lamy; M Leibowitch; J M Huraux; J P Escande
Journal:  Lancet       Date:  1995-03-25       Impact factor: 79.321

8.  Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma.

Authors:  Y Q Huang; J J Li; M H Kaplan; B Poiesz; E Katabira; W C Zhang; D Feiner; A E Friedman-Kien
Journal:  Lancet       Date:  1995-03-25       Impact factor: 79.321

9.  Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma.

Authors:  D Whitby; M R Howard; M Tenant-Flowers; N S Brink; A Copas; C Boshoff; T Hatzioannou; F E Suggett; D M Aldam; A S Denton
Journal:  Lancet       Date:  1995-09-23       Impact factor: 79.321

10.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

View more
  9 in total

1.  Quantitation of cell-free and cell-associated Kaposi's sarcoma-associated herpesvirus DNA by real-time PCR.

Authors:  I E White; T B Campbell
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

2.  Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir.

Authors:  E A Gustafson; R F Schinazi; J D Fingeroth
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay.

Authors:  F Lallemand; N Desire; W Rozenbaum; J C Nicolas; V Marechal
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

4.  Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids.

Authors:  Francesco Broccolo; Giuseppe Locatelli; Loredana Sarmati; Sara Piergiovanni; Fabrizio Veglia; Massimo Andreoni; Stefano Buttò; Barbara Ensoli; Paolo Lusso; Mauro S Malnati
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

5.  Evidence for both lytic replication and tightly regulated human herpesvirus 8 latency in circulating mononuclear cells, with virus loads frequently below common thresholds of detection.

Authors:  Elisa Martró; Michael J Cannon; Sheila C Dollard; Thomas J Spira; A Scott Laney; Chin-Yih Ou; Philip E Pellett
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Comparative evaluation of three serological methods for detection of human herpesvirus 8-specific antibodies in Canadian allogeneic stem cell transplant recipients.

Authors:  Yan Sergerie; Yacine Abed; Jean Roy; Guy Boivin
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

7.  Designing a multi-epitope based vaccine to combat Kaposi Sarcoma utilizing immunoinformatics approach.

Authors:  Varun Chauhan; Tripti Rungta; Kapil Goyal; Mini P Singh
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

Review 8.  Laboratory diagnosis of human herpesvirus 8 infection in humans.

Authors:  R Tedeschi; J Dillner; P De Paoli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-11       Impact factor: 5.103

Review 9.  Kaposi sarcoma herpesvirus pathogenesis.

Authors:  Giuseppe Mariggiò; Sandra Koch; Thomas F Schulz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.